Warming Soils, Rising Infections: The Expanding Global Footprint of Aspergillus

Introduction: Aspergillus on the Rise

Popular media and science journalism frequently captivate the public imagination with dramatic headlines highlighting the emergence of novel or ancient biological entities. Discourse ranges from the discovery of ancient Scottish fossils representing extinct branches of early life, to speculative articles in outlets like the Daily Galaxy discussing unclassified fossil life forms or the role of horizontal gene transfer in triggering early terrestrial ecosystems.¹ While the idea of a "deadly fungus eating the human body" spreading across the planet often serves as a sensationalized hook in popular media, the underlying biological reality is both less dramatic in its immediate appearance and far more concerning in its global public health implications. The true threat does not emanate from a novel, undiscovered alien pathogen, but rather from the quiet, ubiquitous environmental saprophytes that have adapted to a warming world and compromised human immune systems.

Among these, the fungi of the genus Aspergillus, most notably Aspergillus fumigatus, Aspergillus flavus, and Aspergillus niger, represent a profound and escalating challenge.⁴ These molds, naturally tasked with the decomposition of organic matter in soil and compost, possess an extraordinary degree of metabolic plasticity and genomic adaptability.⁷ When inhaled by susceptible individuals, this natural decomposing capability is inadvertently unleashed upon human pulmonary tissue, resulting in aggressive, necrotizing infections that physically degrade the respiratory architecture.⁸ This comprehensive analysis synthesizes current epidemiological trends, predictive ecological modeling, molecular mechanisms of tissue invasion and immune evasion, and the escalating crisis of acquired antifungal resistance to provide a detailed examination of the expanding Aspergillus threat.

The Global Burden of Severe Fungal Pathologies

Historically, fungal pathogens have been systematically under-recognized and underfunded within global health initiatives compared to bacterial and viral counterparts.¹⁰ However, recent extensive epidemiological reviews have clarified the staggering scale of morbidity and mortality driven by these organisms. It is currently estimated that over six point five million individuals develop severe, life-threatening invasive fungal infections globally each year.¹¹ These infections result in approximately three point eight million annual deaths, of which an estimated two point five million are directly attributable to the fungal disease itself rather than underlying host comorbidities.¹¹ This escalating crisis has prompted the formation of international frameworks, such as the Global Action Fund for Fungal Infections, which launched the 95-95 by 2025 initiative aimed at diagnosing and treating ninety-five percent of individuals with serious fungal infections by the end of 2025.¹⁰

Within the broader landscape of mycological disease, Aspergillus species occupy a dominant position in terms of both prevalence and lethality. Annually, over two point one million people develop invasive aspergillosis.¹¹ The incidence is heavily concentrated among specific vulnerable populations, primarily individuals with profound structural lung diseases like chronic obstructive pulmonary disease, intensive care unit patients, individuals with hematological malignancies such as acute leukemia, and recipients of solid organ or hematopoietic stem cell transplants.¹¹ The crude mortality rate for invasive aspergillosis is exceptionally high, calculated at approximately eighty-five point two percent, reflecting both the aggressive nature of the pathogen and the severely compromised state of the typical host.¹¹

Beyond acute invasive disease, Aspergillus drives a massive global burden of chronic and allergic respiratory conditions. Chronic pulmonary aspergillosis affects an estimated one point eight million individuals annually, resulting in roughly three hundred and forty thousand deaths.¹⁰ This chronic manifestation frequently develops in patients with pre-existing cavitary lung disease, most notably as a long-term sequela of pulmonary tuberculosis.⁶ The intersection of tuberculosis and chronic aspergillosis creates distinct geographical disparities in disease burden. For instance, while high-income regions often report high rates of acute invasive disease due to advanced oncological and transplant therapies, the burden of tuberculosis-associated chronic pulmonary aspergillosis is heavily concentrated in the African, Western Pacific, and South-East Asian regions, where baseline tuberculosis rates remain high.¹⁵ Furthermore, fungal asthma, driven by hypersensitivity to inhaled Aspergillus spores, affects approximately eleven point five million people globally and is believed to contribute to tens of thousands of asthma-related fatalities annually.¹⁰

The economic and healthcare infrastructure impacts of these infections are profound. In the United States alone, the hospitalization costs and extended intensive care requirements associated with managing invasive aspergillosis represent a massive financial burden, compounded by the expensive nature of advanced antifungal therapeutics and the prolonged duration of treatment required to clear tissue-invasive molds.¹³

Fungal Disease Category	Estimated Annual Global Incidence	Estimated Annual Deaths	Calculated Crude Mortality Rate	Primary At-Risk Populations
Invasive Aspergillosis	2,113,000	1,801,000	85.2%	Hematological malignancy, ICU patients, transplant recipients
Chronic Pulmonary Aspergillosis	1,837,272	340,000	18.5%	Post-tuberculosis patients, chronic lung cavity patients
Candida Bloodstream Infections	1,565,000	995,000	63.6%	Surgical patients, central venous catheter patients
Pneumocystis Pneumonia	505,000	214,000	42.4%	HIV/AIDS patients, highly immunosuppressed individuals
Cryptococcal Meningitis	194,000	147,000	75.8%	Advanced HIV/AIDS patients

Data synthesized from comprehensive 2024 global health systematic reviews of severe fungal disease incidence and mortality.¹⁰

Climate Change and Predictive Ecological Niche Expansion

The geographical distribution of pathogenic fungi is not static; it is currently undergoing a radical transformation driven by anthropogenic climate change. Fungi are intrinsically adaptable organisms, possessing large, highly plastic genomes that allow them to rapidly adjust their physiology to colonize novel geographic niches as environmental parameters shift.⁷ To understand and anticipate these movements, ecologists and mycologists increasingly rely on advanced computational models, most notably Maximum Entropy modeling.⁴

Maximum Entropy modeling is a machine-learning algorithm utilized to map the potential geographic distribution of a species by correlating documented occurrence records with layers of environmental and bioclimatic data.¹⁷ A distinct advantage of Maximum Entropy modeling is its ability to operate effectively using only presence data, without requiring definitive absence data, making it highly suitable for microscopic organisms like soil fungi where proving absolute absence in a given environment is methodologically difficult.¹⁷ These models typically incorporate nineteen standardized bioclimatic variables, known as Bio1 through Bio19, which capture variations in temperature and precipitation, such as the mean temperature of the coldest quarter, precipitation of the driest quarter, and precipitation of the warmest quarter.¹⁸

When applied to the major Aspergillus pathogens, these predictive models reveal highly specific ecological preferences and alarming trajectories for future expansion. The models confirm that the annual mean temperature is the single most important variable defining the suitable habitat for A. fumigatus, A. flavus, and A. niger.⁴ However, the specific optimal ranges diverge significantly among the species. Aspergillus fumigatus currently demonstrates a strong preference for temperate climates and cooler regions.⁴ It exhibits a distinct affinity for soil environments characterized by high levels of nitrogen and carbon stocks, a high proportion of clay particles, and lower, more acidic pH levels.⁴ Conversely, Aspergillus flavus and Aspergillus niger are biologically optimized for tropical and subtropical environments.⁴ These species dominate in warmer, more arid regions and are frequently recovered from soils with lower organic carbon and nitrogen content, a higher proportion of sand particles, and elevated cation exchange capacities.⁴

Under future climate scenarios, particularly severe warming models such as the Shared Socioeconomic Pathway 5-8.5 scenario, which assumes a continued high global reliance on fossil fuels without significant mitigation, the geographic footprint of these fungi is projected to alter dramatically.⁷ The overarching global trend is a pronounced poleward and northward shift in habitat suitability.⁴ For Aspergillus fumigatus, this translates to a massive expansion of its optimal ecological niche into higher latitudes. Projections indicate that within the next fifteen years, the environmental spread of A. fumigatus in Europe could increase by an estimated seventy-seven point five percent.⁷ This expansion threatens to expose an additional nine million individuals in previously low-risk temperate zones to elevated concentrations of infectious airborne spores, fundamentally altering regional public health risk profiles.⁷

Simultaneously, the ecological shift of Aspergillus flavus carries profound implications for both human disease and global food security. Aspergillus flavus is not only a human pathogen but also a devastating agricultural contaminant responsible for massive crop losses and the production of highly toxic secondary metabolites.⁵ Predictive modeling integrating Maximum Entropy data with spatial maps of global crop distributions indicates that as extreme heat renders some deep tropical regions inhospitable, the suitable habitat for A. flavus will push aggressively northward into critical temperate agricultural zones.⁵ For example, the geographical overlap between A. flavus habitat and major maize and rice cultivation areas is projected to shift, potentially exposing new agricultural belts to severe fungal contamination.⁵ This dual threat of shifting human exposure and compromised agricultural integrity underscores the far-reaching consequences of climate-driven fungal migration.

Pathogen Species	Current Optimal Climate Zone	Preferred Soil Characteristics	Projected Geographic Shift (SSP585 Scenario)	Primary Implications of Range Expansion
Aspergillus fumigatus	Temperate and cooler regions	High nitrogen/carbon, high clay content, low pH	Aggressive northward and poleward expansion; major European spread.	Increased exposure of naive populations to primary pulmonary pathogens.
Aspergillus flavus	Tropical, subtropical, and arid regions	Low nitrogen/carbon, high sand content, high cation exchange capacity	Northward shift; expansion into major temperate agricultural zones.	Rising incidence of granulomatous disease; severe threat to crop security and food supply.
Aspergillus niger	Subtropical and warmer regions	Environment heavily dependent on specific precipitation variables	Northward shift; moderate habitat reduction in extreme tropical heat.	Increased post-harvest crop decay and shifting industrial contamination risks.

Data aggregated from Maximum Entropy ecological niche modeling and predicted climate scenarios.⁴

Mechanisms of Pathogenesis: Tissue Degradation and Angioinvasion

To comprehend the sheer destructiveness of invasive aspergillosis—often hyperbolically described in lay literature as a fungus "eating" the human body—it is necessary to examine the precise biochemical and mechanical strategies the organism employs to dismantle mammalian tissue. The pathogenesis of this disease is fundamentally rooted in the organism's evolutionary history as an environmental decomposer. The enzymatic tools it utilizes to break down complex plant matter in the soil are seamlessly repurposed to degrade human structural proteins when introduced into the pulmonary environment.⁸

The infection cycle initiates with the inhalation of airborne conidia, or spores.⁸ Because Aspergillus species are ubiquitous in the environment, humans inhale hundreds to thousands of these microscopic propagules every day.²⁵ In an individual with a healthy, intact immune system, these spores are rapidly neutralized and cleared by resident alveolar macrophages and the continuous sweeping motion of the respiratory mucociliary escalator.⁹ However, in hosts suffering from profound immunosuppression or widespread viral-induced epithelial damage, the conidia evade immediate clearance, break their metabolic dormancy, and begin to swell.²⁶ This initial isotropic growth is followed by the polarized extension of germ tubes, which rapidly develop into branching, multicellular filamentous structures known as hyphae.²⁶

It is the mature, elongating hyphae that act as the primary engines of tissue destruction. As they grow, the hyphae secrete a vast and highly diverse arsenal of extracellular enzymes designed to liquefy the surrounding environment into assimilable nutrients.⁸ Central to this destructive capability are potent secreted proteases and elastases.⁸ The mammalian lung relies heavily on elastin fibers for its structural integrity, elasticity, and mechanical recoil during respiration. Research has demonstrated that Aspergillus fumigatus can acquire robust elastase activity through rare, random, spontaneous mutations while still residing in the environment, entirely independent of exposure to animal tissues.²⁹ This phenomenon represents a critical evolutionary mechanism whereby preselective mutations acquired for environmental survival inadvertently function as highly potent pathogenicity factors the moment the fungus is inhaled by a human host.²⁹ In addition to elastases, the fungus secretes Alp1, a highly abundant alkaline serine protease that heavily degrades collagen, fibrinogen, and other critical components of the extracellular matrix, effectively dissolving the structural scaffolds of the respiratory epithelium.²⁶

Once the epithelial barrier is enzymatically breached, the advancing hyphae exhibit a pronounced and devastating tropism for blood vessels, a hallmark pathological process known as angioinvasion.⁹ The fungal filaments physically penetrate the endothelial lining of the pulmonary vasculature.⁹ Upon breaching the vessel wall, hyphal fragments can break off into the bloodstream, disseminating the infection to distant organs such as the brain, liver, and kidneys.⁹ Simultaneously, the physical presence of the hyphae within the blood vessel lumen, combined with the severe localized inflammation, induces profound vascular thrombosis.⁹ This clotting entirely occludes the blood vessel, rapidly cutting off the supply of oxygen and essential nutrients to the surrounding lung parenchyma.⁹ Deprived of blood flow, the affected pulmonary tissue undergoes rapid coagulative necrosis, effectively dying in place.⁹ The creation of these expanding zones of dead, infarcted tissue provides the fungus with an idealized, immune-privileged environment perfectly suited for unchecked fungal proliferation, free from circulating white blood cells.⁹

While Aspergillus fumigatus is the primary driver of this rapid, necrotizing angioinvasive pathology, infections caused by Aspergillus flavus often present with distinctly different histological features, particularly when infecting the paranasal sinuses and upper respiratory tract.³³ Aspergillus flavus is the predominant cause of a syndrome known as primary paranasal granuloma, a slowly progressive, locally destructive disease characterized by florid granulomatous inflammation.³⁴ Instead of rapid vascular occlusion, the hallmark of this syndrome is the formation of a hard, dense, irregular, and relatively avascular mass that clinically mimics a malignancy.³⁴ Histologically, this mass is composed of giant cells, histiocytes, lymphocytes, and extensive fibrosis.³⁴ Tissue destruction in these cases is primarily driven by the relentless physical expansion of the granulomatous mass rather than enzymatic liquefaction, leading to severe bone erosion and the direct invasion of adjacent critical structures, including the orbit of the eye and the intracranial cavernous sinus.³⁴

The Host-Pathogen Interface: Sophisticated Immune Evasion

The remarkable capacity of Aspergillus to orchestrate such extensive structural damage relies fundamentally on its ability to systematically blind, dismantle, and evade the host's innate immune system. This host-pathogen conflict is negotiated at the molecular level through a complex array of structural masking techniques, the secretion of potent immunosuppressive toxins, and the direct enzymatic degradation of host immune signaling proteins.²⁶

The initial point of conflict occurs upon inhalation, when host phagocytes attempt to recognize the invading spores using specialized pattern recognition receptors, such as the C-type lectin dectin-1.²⁶ These receptors are evolutionarily tuned to detect specific pathogen-associated molecular patterns on the fungal surface, with the primary target being beta-1,3-glucan, a highly conserved structural polysaccharide integral to the fungal cell wall.³⁶ To avoid this critical detection step, Aspergillus employs highly sophisticated structural masking strategies. The fungus synthesizes and secretes an exopolysaccharide known as galactosaminogalactan, a linear heteropolymer composed of galactose and N-acetylgalactosamine.³⁸

The biosynthesis of this critical molecule is governed by a co-regulated cluster of five genes, which encode necessary glycoside hydrolases (such as Sph3 and Ega3) and deacetylases (such as Agd3).³⁸ After the polymer is exported to the extracellular space, the Agd3 enzyme partially deacetylates the molecule.³⁸ This specific chemical modification is essential; it renders the polymer highly adhesive, allowing it to tightly coat the outer surface of the elongating fungal hyphae.³⁸ This thick, sticky galactosaminogalactan sheath effectively conceals the underlying beta-1,3-glucans from the host.³⁶ By physically masking these inflammatory triggers, the fungus functionally blinds the host's dectin-1 receptors, preventing the activation of a robust, localized pro-inflammatory response and allowing the hyphae to establish a foothold without immediate immunological interference.³⁶

Beyond passive structural masking, Aspergillus engages in aggressive chemical warfare against host leukocytes. The dormant conidia are heavily coated in melanin, a complex pigment integrated into the cell wall that serves to aggressively scavenge and neutralize reactive oxygen species.²⁶ If a spore is engulfed by a macrophage, this melanin armor neutralizes the oxidative burst deployed within the phagolysosome, allowing the spore to survive and germinate from within the host cell.²⁶

As the hyphae mature, they begin to synthesize and release gliotoxin, an exceedingly potent immunosuppressive mycotoxin classified as an epipolythiodioxopiperazine.²⁶ Gliotoxin is highly targeted, specifically penetrating the cell membranes of host neutrophils and macrophages.⁴² Once intracellular, gliotoxin exerts its toxicity by directly inhibiting the nuclear factor kappa B signaling pathway, a central regulatory hub for mammalian immune responses.⁴² The disruption of this critical network immediately halts the production and release of pro-inflammatory cytokines.⁴² Furthermore, gliotoxin actively induces widespread apoptosis, or programmed cell death, in the surrounding immune cells.²⁶ This localized release of chemical suppressants creates a literal dead zone of immune activity around the advancing fungus, clearing a path for unimpeded hyphal extension into the lung parenchyma.²⁶

The fungal arsenal also includes potent countermeasures against the human complement system, a complex biochemical cascade circulating in the blood and tissue fluids that serves to tag pathogens for destruction and recruit inflammatory cells. The previously discussed fungal alkaline serine protease, Alp1, demonstrates a remarkable dual utility; in addition to degrading the extracellular matrix to facilitate physical invasion, Alp1 acts as a highly efficient complement-degrading enzyme.²⁶ Research has demonstrated that Alp1 efficiently cleaves and inactivates central human complement components, specifically C1q, C3, C4, and C5.²⁶ By enzymatically shredding these vital signaling proteins in the immediate extracellular environment, Aspergillus fumigatus prevents the deposition of complement opsonins on its surface, thereby crippling the host's ability to recognize, tag, and phagocytose the invading hyphae.²⁷

Multicellular Organization: Biofilm Formation and Metabolic Plasticity

A critical, yet historically underappreciated, dimension of invasive aspergillosis is the pathogen's ability to transition from individual, free-floating growth to the construction of complex, multicellular biofilms directly within the infected pulmonary tissue.³⁸ A biofilm provides a highly fortified, matrix-enclosed community structure that drastically enhances the organism's resistance to both immunological clearance mechanisms and pharmacological interventions.⁴⁴

The architectural integrity and physical stability of the Aspergillus biofilm are heavily dependent on the copious production of the aforementioned galactosaminogalactan.³⁸ The synthesis and deployment of this extracellular matrix are tightly regulated by overarching genetic networks, heavily governed by master transcription factors such as SomA.³⁸ SomA functions as a central molecular switch within the fungal cell, simultaneously coordinating the complex process of biofilm formation with the rigorous demands of cell wall homeostasis.⁴⁰ By directly binding to specific, conserved sequence motifs in the promoter regions of genes encoding critical glycoside hydrolases and deacetylases, SomA ensures the rapid, coordinated synthesis of the extracellular matrix.³⁸ This tightly regulated matrix acts as a biological adhesive, gluing individual hyphae together into an impenetrable, three-dimensional network, while simultaneously anchoring the entire fungal mass securely to the host's fibronectin and respiratory epithelial cell surfaces.³⁸

Furthermore, the transition from early colonization to a mature, highly structured biofilm architecture is accompanied by a profound and necessary reprogramming of the organism's fundamental metabolism. Advanced molecular techniques, including deep RNA sequencing and comprehensive metabolic flux analyses, have revealed that as the biofilm matures deep within the lung tissue, the fungal cells shift dramatically away from standard, oxygen-dependent respiratory metabolism.⁴⁴ Instead, they adopt highly efficient fermentative metabolic pathways.⁴⁴ This metabolic shift results in the active production of ethanol and butanediol, biochemical signatures strongly indicative of an organism aggressively adapting to the nutrient-deprived, severely oxygen-poor microenvironments that characterize the interior of dense biofilms and necrotic host tissue.⁴⁴ This fermentative plasticity is closely regulated by highly specific transcription factors, such as SilG, whose expression is exclusively upregulated during the critical transition to the mature biofilm stage.⁴⁴ The capacity to fundamentally rewire cellular metabolism at the transcriptional level allows the Aspergillus biofilm to thrive in physiological conditions that would induce rapid starvation, metabolic stalling, and death in less adaptable pathogenic organisms.

Adaptation to the Host Environment: Hypoxia and Thermotolerance

The successful colonization and survival of Aspergillus within the interior of the human body requires the organism to rapidly overcome two severe and simultaneous environmental stressors: the elevated temperature of the mammalian core—which is frequently exacerbated by the host's febrile immune response—and the profound hypoxia that characterizes inflamed, highly metabolically active, and necrotic tissue.²⁸ The evolutionary mechanisms underlying these critical host adaptations trace back to the organism's natural ecological role as a primary decomposer deep within compost piles, where high temperatures generated by microbial metabolism and very low oxygen tensions are the standard environmental conditions.⁸

The adaptation to highly restricted oxygen environments is masterfully orchestrated by a specific sterol-regulatory element binding protein, known as the SrbA transcription factor.⁴⁷ SrbA is a vital regulatory protein that senses dropping oxygen levels in the environment and mounts a massive, coordinated transcriptional response to ensure fungal survival.⁴⁸ One of its primary and most critical roles is to tightly regulate the complex biosynthetic pathway of ergosterol, the fungal equivalent of mammalian cholesterol, which is absolutely essential for maintaining cell membrane fluidity, permeability, and overall structural integrity.⁴⁹ Experimental models utilizing null mutants lacking the SrbA gene exhibit severe, cascading cellular defects. These mutants display abnormal hyphal branching, a complete loss of cell polarity, and an absolute inability to grow under hypoxic conditions, rendering them completely avirulent and easily cleared in mammalian models of invasive disease.⁴⁸ Furthermore, SrbA does not act in isolation; it functions within a broader, highly integrated regulatory network. It interacts with specific promoter sequences, such as AtrR response elements, and closely coordinates with secondary transcription factors like RttA, which specifically controls sterol C24-methyltransferase (Erg6), to meticulously balance sterol homeostasis during periods of severe environmental stress.⁵⁰

In parallel with hypoxia adaptation, the fungus must maintain cellular integrity in the face of significant thermal stress. Thermotolerance in Aspergillus fumigatus is fundamentally anchored by the activity of a ubiquitous and highly conserved molecular chaperone, Heat Shock Protein 90 (Hsp90).²⁸ The initiation of an Aspergillus infection requires dormant conidia, often inhaled from cooler ambient air, to rapidly germinate and undergo complex morphological changes within the sustained heat shock environment of the thirty-seven degree Celsius mammalian lung.²⁸ Hsp90 acts as a vital biochemical stabilizer within the fungal cytoplasm. Operating as a dimeric, functional ATPase, Hsp90 physically interacts with and prevents the thermal aggregation and misfolding of critical signaling proteins.²⁸ Its primary clients are the components of the Cell Wall Integrity Pathway, specifically the essential kinases PkcA and MpkA.²⁸ By maintaining the functional, three-dimensional architecture of these vital regulatory proteins at high temperatures, Hsp90 ensures that the fungus can continually synthesize, remodel, and repair its protective cell wall in the face of both severe thermal stress and the aggressive oxidative and enzymatic attacks launched by the host immune system.²⁸

Master Regulator / Transcription Factor	Primary Biological Function in Pathogenesis	Key Downstream Targets / Pathways	Phenotype of Deletion Mutants
SomA	Coordinates biofilm formation and cell wall homeostasis.	GAG biosynthetic cluster (Sph3, Agd3), chitin synthases, glucan synthases.	Inability to form biofilms; hypersensitivity to cell wall stress; reduced adhesion.
SrbA	Master regulator of hypoxia adaptation and sterol biosynthesis.	Ergosterol synthesis pathway; interacts with RttA and AtrR response elements.	Complete inability to grow in low oxygen; abnormal hyphal branching; avirulent in host.
Hsp90 (Chaperone)	Orchestrates thermotolerance and stress response signaling.	Stabilizes Cell Wall Integrity Pathway kinases (PkcA, MpkA); interacts with calcineurin.	Inability to survive mammalian core temperatures; loss of paradoxical drug resistance.
SilG	Regulates metabolic shifts during late-stage biofilm maturation.	Fermentative metabolic pathways (ethanol, butanediol production).	Arrested biofilm development; inability to mature complex extracellular matrices.

Data aggregated from molecular genetic and transcriptomic analyses of Aspergillus fumigatus regulatory networks.²⁸

The Escalating Global Crisis of Antifungal Resistance

The clinical management of invasive aspergillosis has historically relied upon a relatively narrow armamentarium of specialized antifungal agents. These are primarily categorized into three main classes: the triazoles (such as voriconazole and itraconazole, which target cell membrane sterol synthesis), the polyenes (such as amphotericin B, which physically disrupt the cell membrane), and the echinocandins (such as caspofungin, which inhibit the synthesis of cell wall beta-glucans).⁵³ However, the efficacy of these critical, life-saving therapeutics is rapidly deteriorating worldwide due to a highly concerning global surge in acquired antifungal resistance.⁷

The most alarming development within this sphere is the emergence and rapid transcontinental spread of multi-azole-resistant strains of Aspergillus fumigatus.⁵⁶ The predominant molecular mechanism driving this high-level resistance involves specific, complex mutations in the CYP51A gene, which encodes the precise target enzyme that azole drugs attempt to inhibit.⁵⁶ The most pervasive and problematic of these mutations is a specific combination genetic alteration: a thirty-four base pair tandem repeat sequence inserted into the promoter region of the gene, coupled with a specific amino acid substitution changing a leucine to a histidine at position ninety-eight, collectively designated in the literature as the TR34/L98H mutation.⁵⁶

The epidemiological origin of the TR34/L98H mutation reveals a profound and highly concerning intersection between large-scale industrial agriculture and human clinical medicine. Robust genomic sequencing and expansive ecological sampling strongly suggest that this specific, complex mutation did not evolve gradually within human patients during prolonged courses of clinical therapy.⁵⁷ Rather, it emerged entirely in the external environment as a direct evolutionary consequence of the widespread, intensive application of agricultural demethylation-inhibitor fungicides, which are utilized globally to protect commercial crops from various plant-pathogenic molds.⁵⁷ Because these agricultural fungicides share structural and mechanistic similarities with the triazoles used in human medicine, their massive application exerted intense evolutionary selection pressure on natural, environmental Aspergillus populations living in the soil.⁵⁸

The resulting highly resistant fungal spores, carrying the TR34/L98H mutation, are highly mobile and easily aerosolized. They are subsequently inhaled by susceptible human hosts, leading to primary, environmentally acquired clinical infections that are immediately resistant to first-line medical treatments.⁵⁵ This environmental resistance pipeline has now been definitively documented on a global scale, with the TR34/L98H clone being frequently isolated from tertiary care hospital settings, various occupational environments such as dairy and waste sorting facilities, and agricultural sites across Europe, Asia, and the Americas.⁵⁵

Furthermore, resistance mechanisms are not limited solely to the azole class of drugs. Aspergillus also exhibits highly complex, adaptive, and dynamic stress responses to echinocandins.⁵³ A highly unusual pharmacological phenomenon known as the "paradoxical effect" is frequently observed during treatment with the echinocandin caspofungin.⁵³ During standard susceptibility testing, the drug is highly effective at killing the fungus at intermediate concentrations; however, paradoxically, it entirely loses its fungicidal activity and allows the fungus to resume robust growth when applied at very high concentrations.⁵³ This resilient, compensatory response is intricately orchestrated by the aforementioned molecular chaperone, Hsp90.⁵³ When the fungal cell wall is severely stressed by high concentrations of the drug, Hsp90 interacts with a complex network involving the signaling protein calcineurin and various lysine deacetylases to rapidly initiate compensatory repair mechanisms, effectively reinforcing the cell wall and allowing the fungus to survive massive pharmacological stress.⁵³ Disrupting this specific Hsp90 circuitry—either through targeted Hsp90 inhibitors, calcineurin inhibitors, or specific genetic alterations in the promoter region—effectively abolishes the paradoxical effect, rendering the fungus highly susceptible to the drug once again.⁵³ This highlights the chaperone network as a highly lucrative and necessary target for the development of next-generation, combinatorial antifungal therapeutics.⁵³

Secondary Metabolites and Hepatocellular Carcinogenesis

While active, invasive fungal growth dictates the acute, highly visible pathology of aspergillosis, the latent threat posed by the Aspergillus genus extends deeply into the realms of chronic toxicology, food security, and oncology. Members of this genus are prolific, highly efficient synthesizers of diverse, low-molecular-weight secondary metabolites known as mycotoxins.²⁴ These compounds heavily contaminate global food supplies and agricultural commodities, inflicting profound cellular damage and chronic disease entirely independent of active fungal infection within the host.²⁴

The most notorious and heavily studied of these compounds is Aflatoxin B1, produced predominantly by Aspergillus flavus and closely related species.²⁴ Aflatoxin B1 is universally recognized as one of the most potent naturally occurring hepatic toxins and powerful carcinogens documented in modern medical science, heavily contributing to the massive global burden of early-onset hepatocellular carcinoma.⁶³ The molecular mechanism of aflatoxin-induced carcinogenesis is highly specific and extensively characterized. The process is initiated when the toxin is ingested by humans or animals, usually via the consumption of contaminated staple crops such as maize, cottonseed, or peanuts.²⁴ Upon entering the bloodstream, Aflatoxin B1 is transported to the liver, where it is metabolically activated by specific cytochrome enzymes.⁶³ This highly reactive intermediate then binds directly and covalently to cellular DNA, forming a highly persistent, structurally bulky, and exceptionally mutagenic lesion known as the AFB1-FAPY DNA adduct.⁶⁴

This specific DNA modification presents a massive, physical roadblock to the normal cellular DNA replication machinery.⁶⁵ When the replication fork encounters the adduct and attempts to bypass the damage to avoid cellular arrest, specific, highly error-prone translesion synthesis enzymes are recruited—most likely DNA polymerase zeta.⁶⁴ The replication process across the AFB1-FAPY adduct is highly inaccurate, resulting almost exclusively in a precise guanine to thymine transversion mutation.⁶⁴ Crucially, this specific transversion mutation frequently occurs at codon two hundred and forty-nine of the p53 tumor suppressor gene, a critical guardian of the mammalian genome.⁶⁴ The mutation at this specific hotspot functionally neutralizes the cell's ability to regulate the cell cycle and initiate apoptosis in response to damage, directly and efficiently triggering malignant cellular transformation and the onset of liver cancer.⁶⁴ The remarkable potency of this specific oncogenic pathway necessitates aggressive chemoprotective interventions; promising toxicological research indicates that the synthetic triterpenoid CDDO-Im can powerfully activate host Keap1-Nrf2 antioxidant signaling pathways, conferring near-complete protection against aflatoxin-induced liver cancer in experimental models, notably preventing tumor formation even in the presence of a heavy initial DNA adduct burden.⁶³

Beyond the devastating impact of aflatoxins, the biochemical diversity of the Aspergillus metabolome is vast and poses multiple distinct toxicological threats. Aspergillus niger and related species within the Nigri section are capable of producing over one hundred and forty-five distinct secondary metabolites.⁶² These include highly nephrotoxic compounds like ochratoxin A, which is heavily implicated in chronic kidney disease and urinary tract malignancies; potent cytotoxic cyclic peptides such as the malformins, which induce severe cellular malformations; and a wide array of neurotoxic and immunomodulatory agents including nigragillin and fumonisins.⁶¹ Parallel to this, Aspergillus flavus independently produces a distinct array of potent toxins alongside aflatoxin, including cyclopiazonic acid (which acts as a highly specific inhibitor of intracellular calcium pumps, inducing severe tissue toxicity), the tremorgenic neurotoxin aflatrem, and kojic acid.²⁴ The pervasive presence of these highly stable toxins in agricultural products represents a severe dual threat: they serve as insidious, chronic poisons for human populations consuming contaminated dietary staples, and they simultaneously function as highly potent virulence factors that paralyze local host immune responses when the fungus actively colonizes human tissues.²⁴

Secondary Metabolite / Mycotoxin	Primary Producing Species	Chemical Classification	Primary Mechanism of Toxicity and Biological Impact
Aflatoxin B1	A. flavus, A. parasiticus	Polyketide derivative	Forms highly mutagenic AFB1-FAPY DNA adducts; induces precise G to T transversions in p53; primary driver of hepatocellular carcinoma.
Ochratoxin A	A. niger, A. carbonarius	Isocoumarin derivative	Profound nephrotoxicity; heavily implicated in chronic kidney disease and the development of urinary tract malignancies.
Gliotoxin	A. fumigatus	Epipolythiodioxopiperazine	Potent, targeted immunosuppressant; directly inhibits NF-kappa B signaling; actively induces apoptosis in host neutrophils and macrophages.
Cyclopiazonic Acid	A. flavus	Indole tetramate	Highly specific inhibitor of the sarcoplasmic/endoplasmic reticulum calcium ATPase pump; induces severe cellular and tissue toxicity.
Malformins (A-C)	A. niger	Cyclopentapeptide	Broad-spectrum cytotoxicity; originally identified for inducing severe malformations and structural abnormalities in plant tissues.
Aflatrem	A. flavus	Indole-diterpene	Potent tremorgenic neurotoxin; profoundly disrupts mammalian neurological signaling pathways.

Data aggregated from extensive structural, biochemical, and toxicological analyses of the Aspergillus metabolome.²⁴

Conclusion

The characterization of Aspergillus species as globally expanding, highly destructive pathogens is an accurate reflection of their sophisticated molecular biology, extraordinary evolutionary adaptability, and escalating ecological dominance. The unprecedented convergence of anthropogenic climate change, evolving agricultural practices, and expanding global populations of highly immunocompromised individuals has facilitated a profound and complex global health crisis. As rising global temperatures predictably push environmentally flexible species like Aspergillus fumigatus and Aspergillus flavus into novel, higher-latitude ecological niches, healthcare systems previously unaccustomed to consistently high environmental spore burdens will face increasing incidences of severe, tissue-invasive disease and widespread agricultural mycotoxin contamination.

Furthermore, a detailed examination of the pathogenesis of invasive aspergillosis reveals an organism exquisitely pre-adapted for mammalian tissue destruction. Evolutionary mechanisms forged over millions of years in the hostile, highly competitive environment of decaying organic matter—such as profound hypoxia adaptation via the SrbA transcription factor, robust thermotolerance orchestrated by the Hsp90 chaperone network, and dynamic metabolic shifts toward fermentation within dense, multicellular biofilms—have inadvertently, yet perfectly, armed the fungus for survival within the inflamed, hypoxic, and necrotic landscapes of the human respiratory system. By actively masking its surface antigens with complex polymers like galactosaminogalactan, secreting highly targeted apoptotic toxins like gliotoxin, and physically liquefying structural tissue barriers with arsenals of proteases and acquired elastases, Aspergillus exhibits a multi-tiered, highly redundant capacity to completely overrun host innate immune defenses.

Perhaps most critically, the ongoing, accelerating trajectory of acquired antifungal resistance represents a severe systemic failure of global chemical and pharmacological stewardship. The widespread environmental selection of the multi-azole resistant TR34/L98H mutation, driven entirely by the aggressive application of agricultural fungicides, serves as a stark, undeniable demonstration of how deeply unchecked environmental interventions can compromise essential human clinical outcomes. Addressing the relentlessly expanding footprint of invasive aspergillosis will demand a unified, highly interdisciplinary global approach. It necessitates aggressive, standardized international surveillance of environmental resistance patterns, meticulous, coordinated stewardship of both agricultural and clinical antifungal agents, and the urgent, well-funded development of novel therapeutics specifically targeting the fungus's underlying genetic and metabolic dependencies—such as its master transcription factors, chaperone stabilization networks, and extracellular matrix biosynthetic pathways—before the current, highly limited pharmacological arsenal is rendered entirely obsolete.

Works cited

1. Scientists Just Found a Fossil That Doesn't Belong to Any Known Life Form—What Is It?, accessed February 28, 2026, https://dailygalaxy.com/2025/03/scientists-just-found-a-fossil-that-doesnt-belong-to-any-known-life-form-what-is-it/

2. Giant Scottish Fossil Reveals Extinct Branch Of Life - Grand Pinnacle Tribune, accessed February 28, 2026, https://evrimagaci.org/gpt/giant-scottish-fossil-reveals-extinct-branch-of-life-524998

3. Viruses and Other Gene Transfer Mechanisms. by Brig Klyce - Cosmic Ancestry, accessed February 28, 2026, https://www.panspermia.org/virus.htm

4. Climate change-driven geographical shifts in Aspergillus species ..., accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12933601/

5. Climate models predict spread of deadly Aspergillus pathogens - News-Medical.Net, accessed February 28, 2026, https://www.news-medical.net/news/20250526/Climate-models-predict-spread-of-deadly-Aspergillus-pathogens.aspx

6. Pulmonary aspergillosis: a clinical review - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC9584108/

7. Climate change putting millions more people at risk from infection-causing fungi - The University of Manchester, accessed February 28, 2026, https://www.manchester.ac.uk/about/news/climate-change-putting-millions-more-people-at-risk-from-infection-causing-fungi/

8. Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis - PMC - NIH, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC2708386/

9. Emerging Risk Factors for Invasive Pulmonary Aspergillosis: A Narrative Review - MDPI, accessed February 28, 2026, https://www.mdpi.com/2309-608X/11/8/555

10. The 95-95 by 2025 Initiative: Addressing the Global Fungal Infection Crisis | Contagion Live, accessed February 28, 2026, https://www.contagionlive.com/view/the-95-95-by-2025-initiative-addressing-the-global-fungal-infection-crisis

11. Global incidence and mortality of severe fungal disease - PubMed, accessed February 28, 2026, https://pubmed.ncbi.nlm.nih.gov/38224705/

12. Fungal Infections: A Rising Global Concern by ISID Emerging Leader, Afreenish Amir, accessed February 28, 2026, https://isid.org/fungal-infections-a-rising-global-concern-by-isid-emerging-leader-afreenish-amir/

13. Healthcare Resource Utilization, Treatment Costs, and Mortality in Patients with Malignancies or Transplantation Who Develop Invasive Aspergillosis - MDPI, accessed February 28, 2026, https://www.mdpi.com/2309-608X/11/9/657

14. Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta‐analysis - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC9306612/

15. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC3260898/

16. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC5753159/

17. Nematophagous Fungi Occurrence: Prediction Using Bioclimatic Variables - MDPI, accessed February 28, 2026, https://www.mdpi.com/2036-7481/16/5/98

18. Maxent modeling for predicting the potential distribution of Sanghuang, an important group of medicinal fungi in China - ResearchGate, accessed February 28, 2026, https://www.researchgate.net/publication/282557662_Maxent_modeling_for_predicting_the_potential_distribution_of_Sanghuang_an_important_group_of_medicinal_fungi_in_China

19. Distribution and ecological niche modeling of a rare species Poronia punctata in Asia - Current Research in Environmental & Applied Mycology (Journal of Fungal Biology), accessed February 28, 2026, https://www.creamjournal.org/pdf/CREAM_11_1_32.pdf

20. Project webpage: http://ibot.sav.sk/dipofungi-en/ Future directions Environmental niches modelled in Principal Component Analysi, accessed February 28, 2026, https://cbrb.sav.sk/wp-content/uploads/mem/pdf/Distribution_limits.pdf

21. Estimating the Climate Niche of Sclerotinia sclerotiorum Using Maximum Entropy Modeling, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10532795/

22. Climate change-driven geographical shifts in Aspergillus species habitat and the implications for plant and human health - ScienceOpen, accessed February 28, 2026, https://www.scienceopen.com/document?vid=7dfa56a9-d865-45a8-b034-ff7969572f55

23. Overview of characteristics of A. fumigatus compared to A. flavus, A. nidulans, A. niger and A. terreus. - ResearchGate, accessed February 28, 2026, https://www.researchgate.net/figure/Overview-of-characteristics-of-A-fumigatus-compared-to-A-flavus-A-nidulans-A-niger_tbl1_370244484

24. Comparison of Expression of Secondary Metabolite Biosynthesis Cluster Genes in Aspergillus flavus, A. parasiticus, and A. oryzae - MDPI, accessed February 28, 2026, https://www.mdpi.com/2072-6651/6/6/1916

25. Aspergillus fumigatus: Principles of Pathogenesis and Host Defense | Eukaryotic Cell, accessed February 28, 2026, https://journals.asm.org/doi/10.1128/ec.00274-07

26. Interference of Aspergillus fumigatus with the immune response - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC4326658/

27. Secreted Aspergillus fumigatus Protease Alp1 Degrades Human Complement Proteins C3, C4, and C5 | Infection and Immunity - ASM Journals, accessed February 28, 2026, https://journals.asm.org/doi/10.1128/iai.01353-09

28. Aspergillus fumigatus Hsp90 interacts with the main components of the cell wall integrity pathway and cooperates in heat shock a - eScholarship, accessed February 28, 2026, https://escholarship.org/content/qt1681p3vs/qt1681p3vs.pdf

29. (PDF) Elastase Activity in Aspergillus fumigatus Can Arise by Random, Spontaneous Mutations - ResearchGate, accessed February 28, 2026, https://www.researchgate.net/publication/50196622_Elastase_Activity_in_Aspergillus_fumigatus_Can_Arise_by_Random_Spontaneous_Mutations

30. Elastase Activity in Aspergillus fumigatus Can Arise by Random, Spontaneous Mutations, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC3042605/

31. Aspergillus Fumigatus Spore Proteases Alter the Respiratory Mucosa Architecture and Facilitate Equine Herpesvirus 1 Infection - MDPI, accessed February 28, 2026, https://www.mdpi.com/1999-4915/16/8/1208

32. Current Approaches to Diagnosis and Treatment of Invasive Aspergillosis - ATS Journals, accessed February 28, 2026, https://www.atsjournals.org/doi/10.1164/rccm.200505-727SO

33. Chronic Necrotizing Bronchopulmonary Aspergillosis With Elements of Bronchocentric Granulomatosis - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC4531665/

34. invasive and saprophytic syndromes due to Aspergillus spp. - Oxford Academic, accessed February 28, 2026, https://academic.oup.com/mmy/article/43/Supplement_1/S207/1746898

35. The Pathogenesis of Aspergillus fumigatus, Host Defense Mechanisms, and the Development of AFMP4 Antigen as a Vaccine - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC8008755/

36. Full article: Galactosaminogalactan (GAG) and its multiple roles in Aspergillus pathogenesis, accessed February 28, 2026, https://www.tandfonline.com/doi/full/10.1080/21505594.2019.1568174

37. The Fungal Cell Wall: Structure, Biosynthesis, and Function | Microbiology Spectrum, accessed February 28, 2026, https://journals.asm.org/doi/10.1128/microbiolspec.funk-0035-2016

38. GAG - Howell Lab - SickKids Research Institute, accessed February 28, 2026, https://lab.research.sickkids.ca/howell/molecular-mechanisms/exopolysaccharides/gag/

39. Galactosaminogalactan (GAG) and its multiple roles in Aspergillus pathogenesis - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC8647848/

40. The Transcription Factor SomA Synchronously Regulates Biofilm Formation and Cell Wall Homeostasis in Aspergillus fumigatus | mBio - ASM Journals, accessed February 28, 2026, https://journals.asm.org/doi/10.1128/mbio.02329-20

41. Aspergillus Galactosaminogalactan Mediates Adherence to Host Constituents and Conceals Hyphal β-Glucan from the Immune System - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC3749958/

42. Molecular Insights into Pathogenesis and Infection with Aspergillus Fumigatus - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC5345999/

43. Pathogenicity and virulence of Aspergillus fumigatus - Taylor & Francis, accessed February 28, 2026, https://www.tandfonline.com/doi/full/10.1080/21505594.2023.2172264

44. Transcriptional and metabolic modeling analyses of developing Aspergillus fumigatus biofilms reveal metabolic shifts required for biofilm maturation - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12724364/

45. Aspergillus fumigatus biofilms: Toward understanding how growth as a multicellular network increases antifungal resistance and disease progression - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC8389518/

46. Transcriptional analysis of developing Aspergillus fumigatus biofilms reveals metabolic shifts required for biofilm maintenance | bioRxiv, accessed February 28, 2026, https://www.biorxiv.org/content/10.1101/2025.06.02.657448v1.full-text

47. Aspergillus fumigatus hypoxia adaptation is critical for the establishment of fungal keratitis, accessed February 28, 2026, https://www.biorxiv.org/content/10.1101/2023.10.01.560368v1.full-text

48. A Sterol-Regulatory Element Binding Protein Is Required for Cell Polarity, Hypoxia Adaptation, Azole Drug Resistance, and Virulence in Aspergillus fumigatus - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC2572145/

49. A Sterol-Regulatory Element Binding Protein Is Required for Cell Polarity, Hypoxia Adaptation, Azole Drug Resistance, and Virulence in Aspergillus fumigatus | PLOS Pathogens - Research journals, accessed February 28, 2026, https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1000200

50. The transcription factor RttA contributes to sterol regulation and azole resistance in Aspergillus fumigatus | mBio - ASM Journals, accessed February 28, 2026, https://journals.asm.org/doi/10.1128/mbio.01854-25

51. AtrR Is an Essential Determinant of Azole Resistance in Aspergillus fumigatus - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC6414702/

52. Hsp90 orchestrates stress response signaling governing fungal drug resistance - PubMed, accessed February 28, 2026, https://pubmed.ncbi.nlm.nih.gov/19714223/

53. Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus, accessed February 28, 2026, https://pubmed.ncbi.nlm.nih.gov/25243616/

54. The Aspergillus fumigatus cell wall integrity signaling pathway: drug target, compensatory pathways, and virulence - Frontiers, accessed February 28, 2026, https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2015.00325/full

55. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil | Antimicrobial Agents and Chemotherapy - ASM Journals, accessed February 28, 2026, https://journals.asm.org/doi/10.1128/aac.02059-19

56. TR34/L98H Mutation in CYP51A Gene in Aspergillus fumigatus Clinical Isolates During Posaconazole Prophylaxis: First Case in Korea - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC6096900/

57. Azole-Resistant Aspergillus fumigatus Among Danish Cystic Fibrosis Patients: Increasing Prevalence and Dominance of TR34/L98H - Frontiers, accessed February 28, 2026, https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2020.01850/full

58. Azole-Resistant Aspergillus fumigatus Harboring the TR34/L98H Mutation: First Report in Portugal in Environmental Samples - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC7823791/

59. Multiple cyp51A-Based Mechanisms Identified in Azole-Resistant Isolates of Aspergillus fumigatus from China - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC4468671/

60. Transcriptional Activation of Heat Shock Protein 90 Mediated Via a Proximal Promoter Region as Trigger of Caspofungin Resistance in Aspergillus fumigatus | The Journal of Infectious Diseases | Oxford Academic, accessed February 28, 2026, https://academic.oup.com/jid/article/209/3/473/842725

61. Draft Screening Assessment for Aspergillus awamori ATCC 22342 (=A. niger ATCC 22342) and Aspergillus brasiliensis ATCC 9642 - Canada.ca, accessed February 28, 2026, https://www.canada.ca/en/environment-climate-change/services/evaluating-existing-substances/draft-screening-assessmentaspergillus-awamori-atcc-22342-a-niger-atcc-22342aspergillus-brasiliensis-atcc-964.html

62. Review of secondary metabolites and mycotoxins from the Aspergillus niger group, accessed February 28, 2026, https://www.researchgate.net/publication/26814343_Review_of_secondary_metabolites_and_mycotoxins_from_the_Aspergillus_niger_group

63. Complete Protection against Aflatoxin B1-Induced Liver Cancer with a Triterpenoid: DNA Adduct Dosimetry, Molecular Signature, and Genotoxicity Threshold - AACR Journals, accessed February 28, 2026, https://aacrjournals.org/cancerpreventionresearch/article/7/7/658/50366/Complete-Protection-against-Aflatoxin-B1-Induced

64. Molecular basis of aflatoxin-induced mutagenesis—role of the aflatoxin B1-formamidopyrimidine adduct - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC4076807/

65. The aflatoxin B1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma | PNAS, accessed February 28, 2026, https://www.pnas.org/doi/10.1073/pnas.102167699

66. Aflatoxin B1-DNA Adduct Formation and Mutagenicity in Livers of Neonatal Male and Female B6C3F1 Mice - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC3143467/

67. accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC5392321/#:~:text=In%20summary%2C%20we%20found%20that,mutational%20hotspot%20in%20AFB1%20related

68. Aspergillus niger as a Secondary Metabolite Factory - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC8362661/

69. Aspergillus niger: A Hundred Years of Contribution to the Natural Products Chemistry, accessed February 28, 2026, https://www.scielo.br/j/jbchs/a/Ksq9RGvtGTTbtw8vp7NN4kv/?lang=en

70. Review of secondary metabolites and mycotoxins from the Aspergillus niger group, accessed February 28, 2026, https://pubmed.ncbi.nlm.nih.gov/19756540/

71. Secondary Metabolite Dereplication and Phylogenetic Analysis Identify Various Emerging Mycotoxins and Reveal the High Intra-Species Diversity in Aspergillus flavus - Frontiers, accessed February 28, 2026, https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2019.00667/full

72. Aspergillus flavus Secondary Metabolites: More than Just Aflatoxins - PMC, accessed February 28, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC6989186/